Affiliation:
1. Departments of Pediatrics
2. Laboratory Medicine
3. Pathology, University of California San Francisco Medical Center, San Francisco, California
Abstract
BACKGROUND AND OBJECTIVES
In previous studies, researchers highlight that children have higher rates of transfusion reactions than adults. However, little is known about the pediatric populations that experience reactions, and there are no reports that consider appropriateness of pediatric transfusions in relation to preventable harm. With this study, we aim to describe pediatric transfusion reactions occurring at an academic institution and to quantify transfusion reactions that resulted from inappropriate transfusion indications, thereby identifying an area of potentially preventable patient harm (PPH).
METHODS
This is a case series of acute transfusion reactions in pediatric patients at a single institution from January 2018 to December 2019. We reviewed patient data, clinical documentation, and transfusion reaction reports to determine the appropriateness of transfusions and calculate PPH.
RESULTS
A total 155 acute transfusion reactions occurred in 106 pediatric patients, amounting to a total reaction rate of 544 of 100 000 transfusions. In 65% of reactions, the indication for transfusion was appropriate by institutional standards; 23% had questionable indication; and 12% were not indicated. The rate of potential PPH from inappropriate transfusions was 67 of 100 000 transfusions.
CONCLUSIONS
Transfusion reactions that occur during inappropriately ordered blood transfusions represent PPH. Efforts should be made to develop transfusion guidelines, standardize practice, and educate physicians to prevent transfusion-related harm.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics,General Medicine,Pediatrics, Perinatology and Child Health
Reference17 articles.
1. Transfusion-associated adverse events and implementation of blood safety measures – findings from the 2017 National Blood Collection and Utilization Survey;Savinkina;Transfusion,2020
2. Safety incident reports associated with blood transfusions;Vossoughi;Transfusion,2019
3. National Healthcare Safety Network. Biovigilance Component Hemovigilance Module Surveillance Protocol v2.6. Available at: https://www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf. Accessed April 15, 2021
4. Analysis of pediatric adverse reactions to transfusions;Vossoughi;Transfusion,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献